alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                                                                   EXHIBIT 32(a)

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the filing of this quarterly report on Form 10-Q of TRW
Automotive Holdings Corp. (the "Company") for the period ended June 25, 2004,
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, John C. Plant, Chief Executive Officer of the Company, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

      1)    The Report fully complies with the requirements of section 13(a) or
            15(d) of the Securities Exchange Act of 1934; and

      2)    The information contained in the Report fairly presents, in all
            material respects, the financial condition and results of operations
            of the Company.

Date: July 28, 2004                        /s/ John C. Plant
                                           -------------------------------------
                                           John C. Plant
                                           Chief Executive Officer and President
                                           (Principal Executive Officer)

                                       42
IN THE UNITED STATES DISTRICT COURT 

FOR THE EASTERN DISTRICT OF TEXAS 

MARSHALL DIVISION 

PAR PHARMACEUTICAL, INC., and ENDO 

PAR INNOVATION COMPANY, LLC, 

 Plaintiffs, 

v. 

MANKIND PHARMA LIMITED 

 Defendant. 

)

)

)

)

)

)

)

)

)

)

) 

) 

C.A. No. 2:23cv-00399-JRG-RSP 

JURY DEMAND 

Pursuant to Local Rule CV-38(a), Plaintiffs respectfully demand a jury trial on all issues 

so triable. 

Case 2:23-cv-00399-JRG-RSP Document 29 Filed 09/27/23 Page 1 of 3 PageID #: 811
Dated: September 27, 2023 Respectfully submitted, 

/s/ Martin J. Black by permission Andrea L. 

Fair 

Martin J. Black – LEAD ATTORNEY 

Robert D. Rhoad 

Sharon K. Gagliardi 

Brian M. Goldberg 

Luke M. Reilly 

Daniel R. Roberts 

DECHERT LLP 

Cira Centre 

2929 Arch Street 

Philadelphia, PA 19104 

Tel: (215) 994-4000 

martin.black@dechert.com 

robert.rhoad@dechert.com 

sharon.gagliardi@dechert.com 

brian.goldberg@dechert.com 

luke.reilly@dechert.com 

daniel.roberts@dechert.com 

Jonathan D.J. Loeb, Ph.D. 

DECHERT LLP 

2400 W. El Camino Real, Suite 700 

Mountain View, CA 94040-1499 

Tel: (650) 813-4995 

jonathan.loeb@dechert.com 

OF COUNSEL: 

Andrea L. Fair 

Texas Bar No. 24078488 

WARD, SMITH & HILL, PLLC 

1507 Bill Owens Pkwy. 

Longview, TX 75604 

Tel: (903) 757-6400 

andrea@wsfirm.com 

Attorneys for Plaintiffs Par Pharmaceutical, 

Inc. and Endo Par Innovation Company, LLC

 

Case 2:23-cv-00399-JRG-RSP Document 29 Filed 09/27/23 Page 2 of 3 PageID #: 812
CERTIFICATE OF SERVICE

I hereby certify that, on September 27, 2023, the foregoing document was filed 

electronically in compliance with Local Rule CV-5(a), which will provide notice of the same to 

all counsel of record. 

/s/ Andrea L. Fair 

Andrea L. Fair 

Case 2:23-cv-00399-JRG-RSP Document 29 Filed 09/27/23 Page 3 of 3 PageID #: 813
IN RE Corey Devon EATON, Petitioner.

No. 19-7154.

Supreme Court of the United States.

April 27, 2020

Petition for rehearing denied.
Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Smurfit-Stone Container Corporation (the "Company") on Form 10-K for the period ending
December 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Charles A. Hinrichs, Vice President and Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)   The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)   The
information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

|/s/CHARLES A. HINRICHSCharles A. Hinrichs
Vice President and Chief Financial Officer | 
|------------------------------------------------------------------------------------ | 
|March 3, 2004                                                                        | 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging or otherwise adopting the signature
that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Smurfit-Stone Container Corporation and will be retained by
Smurfit-Stone Container Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

---

QuickLinks
[Federal Register Volume 87, Number 111 (Thursday, June 9, 2022)]
[Notices]
[Page 35226]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-12443]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; National Center for Advancing 
Translation Sciences Emphasis Panel.
    Date: July 7, 2022.
    Time: 1:00 p.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, 6701 Rockledge Drive, Room 1037, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Rahat (Rani) Khan, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Center for Advancing 
Translational Sciences, 6701 Rockledge Drive, Room 1037, Bethesda, 
MD 20892, (301) 594-7319, <a href="/cdn-cgi/l/email-protection#62090a030c1050220111104c0c0b0a4c050d14"><span class="__cf_email__" data-cfemail="cba0a3aaa5b9f98ba8b8b9e5a5a2a3e5aca4bd">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: June 6, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-12443 Filed 6-8-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<TABLE> <S> <C>

<ARTICLE> 6
<CIK> 0000775370
<NAME> SMITH BARNEY MUNI FUNDS
<SERIES>
   <NUMBER> 7
   <NAME> FLORIDA PORTFOLIO. CLASS L

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          MAR-31-2000
<PERIOD-END>                               SEP-30-1999
<INVESTMENTS-AT-COST>                      211,293,298
<INVESTMENTS-AT-VALUE>                     223,562,764
<RECEIVABLES>                               11,605,342
<ASSETS-OTHER>                                       0
<OTHER-ITEMS-ASSETS>                                 0
<TOTAL-ASSETS>                             235,168,106
<PAYABLE-FOR-SECURITIES>                     9,977,553
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                    3,288,562
<TOTAL-LIABILITIES>                         13,266,115
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                   222,100,347
<SHARES-COMMON-STOCK>                          952,816
<SHARES-COMMON-PRIOR>                          894,368
<ACCUMULATED-NII-CURRENT>                        1,997
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                    (2,469,819)
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                     2,269,466
<NET-ASSETS>                               221,901,991
<DIVIDEND-INCOME>                                    0
<INTEREST-INCOME>                            6,778,547
<OTHER-INCOME>                                       0
<EXPENSES-NET>                               1,047,532
<NET-INVESTMENT-INCOME>                      5,731,015
<REALIZED-GAINS-CURRENT>                   (2,203,615)
<APPREC-INCREASE-CURRENT>                 (12,151,911)
<NET-CHANGE-FROM-OPS>                      (8,624,511)
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                      283,262
<DISTRIBUTIONS-OF-GAINS>                             0
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                        125,830
<NUMBER-OF-SHARES-REDEEMED>                     79,009
<SHARES-REINVESTED>                             11,627
<NET-CHANGE-IN-ASSETS>                    (15,809,791)
<ACCUMULATED-NII-PRIOR>                        (9,378)
<ACCUMULATED-GAINS-PRIOR>                    (266,204)
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                          578,072
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                              1,047,532
<AVERAGE-NET-ASSETS>                        12,422,230
<PER-SHARE-NAV-BEGIN>                            13.69
<PER-SHARE-NII>                                  00.30
<PER-SHARE-GAIN-APPREC>                         (0.83)
<PER-SHARE-DIVIDEND>                             00.30
<PER-SHARE-DISTRIBUTIONS>                            0
<RETURNS-OF-CAPITAL>                                 0
<PER-SHARE-NAV-END>                              12.86
<EXPENSE-RATIO>                                  01.31


</TABLE>
Maurice Samuel ARRINGTON, Petitioner, v. Lorie DAVIS, Director, Texas Department of Criminal Justice, Correctional Institutions Division.

No. 19-5104.

Supreme Court of the United States.

Oct. 7, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
James Nathaniel DOUSE, Petitioner, v. UNITED STATES, et al.

No. 19-737.

Supreme Court of the United States.

June 1, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
Aaron Clayton MCVEA, Petitioner, v. UNITED STATES

No. 19-5083

Supreme Court of the United States.

October 7, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
Fourth Court of Appeals

San Antonio, Texas

February 26, 2021

No. 04-21-00072-CR

Christian William PFISTER,

Appellant

v.

The STATE of Texas,

Appellee

From the County Court At Law No 2, Guadalupe County, Texas

Trial Court No. CCL-20-0273

Honorable Frank Follis, Judge Presiding

O R D E R

On February 25, 2021, the district clerk filed a copy of the clerk’s record, which contains 

the trial court’s certification, stating this “is a plea-bargain case, and the defendant has NO right 

of appeal.” We therefore ORDER the district clerk to file, by March 8, 2021, an electronic 

clerk’s record containing the following documents: 

1. All pre-trial orders and the related pre-trial motions;

2. The Court Admonishments, the Waiver, Consent to Stipulation of Testimony and 

Stipulations, and all other documents relating to the defendant’s plea bargain;

3. The judgment;

4. All post-judgment motions and orders;

5. The notice of appeal;

6. The Trial Court’s Certification of Defendant’s Right of Appeal; and

7. The criminal docket sheet.

All other appellate deadlines are suspended pending further order of this court.
_________________________________

Rebeca C. Martinez, Chief Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 26th day of February, 2021.

___________________________________

Michael A. Cruz, 

Clerk of Court
Douglas Cornell JACKSON, Petitioner, v. Leah BEREAN, et al.

No. 19-7702.

Supreme Court of the United States.

April 27, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
Irma ROSAS, Petitioner, v. UNIVERSITY OF TEXAS AT SAN ANTONIO, et al.

No. 19M137.

Supreme Court of the United States.

May 18, 2020

Motion to direct the Clerk to file a petition for writ of certiorari out of time denied.
Dannez W. HUNTER, Petitioner, v. Keith Rupert MURDOCH, et al.; Joseph's/Candler Health System, Inc.

No. 19-6630.

Supreme Court of the United States.

April 20, 2020

The petition for rehearing is denied.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                          72,926
<SECURITIES>                                         0
<RECEIVABLES>                                  111,475
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,178,106
<PP&E>                                       4,095,574
<DEPRECIATION>                               (507,520)
<TOTAL-ASSETS>                               4,950,561
<CURRENT-LIABILITIES>                          170,984
<BONDS>                                      2,598,929
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                    200,000
<COMMON>                                         1,208
<OTHER-SE>                                   1,979,440
<TOTAL-LIABILITY-AND-EQUITY>                 4,950,561
<SALES>                                              0
<TOTAL-REVENUES>                               746,279
<CGS>                                                0
<TOTAL-COSTS>                                  609,200
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             192,033
<INCOME-PRETAX>                                (7,441)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (7,441)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (7,441)
<EPS-BASIC>                                     (0.06)
<EPS-DILUTED>                                   (0.06)


</TABLE>
# C_2018220EN.01000101.xml

| 25.6.2018 | EN | Official Journal of the European Union | C 220/1 |
| --- | --- | --- | --- |

25.6.2018

EN

Official Journal of the European Union

C 220/1

---

Non-opposition to a notified concentration

(Case M.8940 — Blackstone/Cirsa)

(Text with EEA relevance)

(2018/C 220/01)

On 14 June 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

1

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M8940. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M8940. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

---
Carl LABAT, Petitioner, v. Darrel VANNOY, Warden.

No. 19-6701.

Supreme Court of the United States.

May 18, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
# C_2017220EN.01005701.xml

| 8.7.2017 | EN | Official Journal of the European Union | C 220/57 |
| --- | --- | --- | --- |

8.7.2017

EN

Official Journal of the European Union

C 220/57

---

Commission information notice pursuant to Article 16(4) of Regulation (EC) No 1008/2008 of the European Parliament and of the Council on common rules for the operation of air services in the Community

Establishment of public service obligations in respect of scheduled air services

(Text with EEA relevance)

(2017/C 220/09)

| Member State | Italy |
| --- | --- |
| Routes concerned | Alghero-Rome Fiumicino and vice versa
  Alghero-Milan Linate and vice versa
  Cagliari-Rome Fiumicino and vice versa
  Cagliari-Milan Linate and vice versa
  Olbia-Rome Fiumicino and vice versa
  Olbia-Milan Linate and vice versa |
| New date of entry into force of the public service obligations | 9 November 2017 |
| Address where the text and any information and/or documentation relating to the public service obligation can be obtained | Reference document


  OJ C 145, 9.5.2017, p. 4.
  For further information, please contact:





  Ministry of Infrastructure and Transport |
| Directorate-General for Airports and Air Transport |
| Tel. +39 0641583681/3683 |
| Email: segreteria_dgata@pec.mit.gov.it |
| Website: http://www.mit.gov.it |

Member State

Italy

Routes concerned

Alghero-Rome Fiumicino and vice versa

Alghero-Milan Linate and vice versa

Cagliari-Rome Fiumicino and vice versa

Cagliari-Milan Linate and vice versa

Olbia-Rome Fiumicino and vice versa

Olbia-Milan Linate and vice versa

New date of entry into force of the public service obligations

9 November 2017

Address where the text and any information and/or documentation relating to the public service obligation can be obtained

Reference document

Reference document

OJ C 145, 9.5.2017, p. 4.

For further information, please contact:

Ministry of Infrastructure and Transport

Directorate-General for Airports and Air Transport

Tel. +39 0641583681/3683

Email: segreteria_dgata@pec.mit.gov.it

Website: http://www.mit.gov.it

| Autonomous Region of Sardinia |
| --- |
| Department of Transport |
| Directorate-General for Transport |
| Service for Maritime and Air Transport and Territorial Continuity |
| Tel. +39 0706067331 |
| Fax +39 0706067309 |
| Website: http://www.regione.sardegna.it |
| Email | : | trasporti@pec.regione.sardegna.it
  trasporti@regione.sardegna.it
  trasp.osp@regione.sardegna.it |

Autonomous Region of Sardinia

Department of Transport

Directorate-General for Transport

Service for Maritime and Air Transport and Territorial Continuity

Tel. +39 0706067331

Fax +39 0706067309

Website: http://www.regione.sardegna.it

Email

:

trasporti@pec.regione.sardegna.it

trasporti@regione.sardegna.it

trasp.osp@regione.sardegna.it

---
Javed ASEFI, Petitioner, v. UNITED STATES.

No. 19-7566.

Supreme Court of the United States.

March 9, 2020.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
N OTE : This disposition is nonprecedential.



# United States **Court of Appeals**  **for the Federal Circuit**

______________________

GEORGE A. VAUGHN,
Claimant

- Appellant

v.

ROBERT WILKIE, SECRETARY OF VETERAN S AFFAIRS, Respondent

- Appellee

______________________

2018

- 1073

______________________

Appeal from the United States Court of Appeals for
Veterans Claims in No. 16

- 1616, Chief Judge Robert N. Davis.

______________________

JUDGMENT

______________________

K ENNETH M. C ARPENTER

, Law Offices of Carpenter Chartered, Topeka, KS, argued for claimant

- appellant.

I SAAC B. R OSENBERG , Commercial Litigation Branch, Civil Division, United States Department of Justice, Washington, DC, a rgued for respondent

- appellee. Also represented by J OSEPH H. H UNT

, C LAUDIA B URKE

, R OBERT E DWARD K IRSCHMAN

, J R

. ; C HRISTOPHER O. A DELOYE

, Y.K EN L EE , Office of General Counsel, United States Department of Veterans Affairs, Washington, DC

.

______________________

T HIS C AUSE ha ving been heard and considered, it is

O RDERED and A DJUDGED :

P ER C URIAM (L OURIE

, M AYER

, and R EYNA

, Circuit Judges ).

AFFIRMED. See Fed . Cir. R. 36.

E NTERED BY O RDER OF THE C OURT

February 8, 2019 /s/ Peter R. Marksteiner

Date Peter R. Marksteiner
Clerk of Court
# Fourth Court of Appeals

**San Antonio, Texas**

JUDG MENT

No. 04

- 13

- 00164

- CR

Jerry VILLARREAL

, Appellant

v.

The State of

The STATE of Texas,

Appellee

From the 226th Judicial District Court, Bexar County, Texas

Trial Court No. 2012CR5560

Honorable Dick Alcala, Judge Presiding

BEFORE JUSTICE MARION, JUSTICE BARNARD , AND JUSTICE MARTINEZ

In accordance with this court’s opinion of this date, this appeal is DISMISSED.

SIGNED May 15, 2013.

_________________________________ Sandee Bryan Marion, Justice
Arthur DURHAM, Petitioner v. UNITED STATES

No. 19-5124

Supreme Court of the United States.

October 7, 2019

Petition for writ of certiorari to the United States Court of Appeals for the First Circuit denied.
```
 
 
VIX FUTURES - CBOE FUTURES EXCHANGE                                  Code-1170E1
FUTURES ONLY POSITIONS AS OF 08/05/14                         |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  LONG  | SHORT  |SPREADS |  LONG  | SHORT  |  LONG  | SHORT  |  LONG  | SHORT
--------------------------------------------------------------------------------
($1000 X INDEX)                                      OPEN INTEREST:      409,891
COMMITMENTS
 122,438  156,976  115,286  145,580  105,997  383,304  378,259   26,587   31,632

CHANGES FROM 07/29/14 (CHANGE IN OPEN INTEREST:    -10,055)
 -11,413  -36,389   13,137  -12,709   10,716  -10,985  -12,536      930    2,481

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADERS
    29.9     38.3     28.1     35.5     25.9     93.5     92.3      6.5      7.7

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      187)
      65       65       84       41       40      152      154
```

----

Updated August 8, 2014
IN THE SUPREME COURT OF PENNSYLVANIA

WESTERN DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

ROBERT L. BURGESS,

Petitioner :

:

:

:

:

:

:

:

:

:

: No. 367 WAL 2016

Petition for Allowance of Appeal from

the Order of the Superior Court

ORDER

PER CURIAM

AND NOW , this 28th day of February, 2017

, the Petition for Allowance of Appeal

is DENIED

.